Sionna Therapeutics (SION) Treasury Shares (2024)

Sionna Therapeutics (SION) posted Treasury Shares of $18.6 million for Q4 2024, little changed sequentially from $18.6 million in Q3 2024.

Sionna Therapeutics (SION) Treasury Shares (2024) Analysis & Trends

Sionna Therapeutics has reported Treasury Shares for 1 years, with the latest figure at $18.6 million in Q4 2024.

Quarterly Treasury Shares changed N/A year-over-year to $18.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $18.6 million (changed N/A YoY) and the FY2024 annual result came in at $18.6 million, changed N/A from the prior year.
Treasury Shares was little changed at $18.6 million in Q4 2024 per SION's latest filing, from $18.6 million in the prior quarter.
Over five years, Treasury Shares peaked at $18.6 million in Q1 2024 and troughed at $18.6 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Sionna Therapeutics	291.76 Mn	291.76 Mn	-	-

Download Data